CarsonAllaria Wealth Management’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-104
| Closed | -$328 | – | 415 |
|
|
2023
Q2 | $328 | Hold |
104
| – | – | ﹤0.01% | 377 |
|
|
2023
Q1 | $278 | Hold |
104
| – | – | ﹤0.01% | 363 |
|
|
2022
Q4 | $0 | Sell |
104
-58
| -36% | – | ﹤0.01% | 372 |
|
|
2022
Q3 | $1K | Sell |
162
-1
| -0.6% | -$6 | ﹤0.01% | 329 |
|
|
2022
Q2 | $2K | Hold |
163
| – | – | ﹤0.01% | 292 |
|
|
2022
Q1 | $2K | Hold |
163
| – | – | ﹤0.01% | 310 |
|
|
2021
Q4 | $5K | Buy |
+163
| New | +$5K | ﹤0.01% | 276 |
|